Insulet Newsroom

Insulet Is Maintained at Buy by BTIG

Dow JonesOct 15 01:04

Insulet Analyst Ratings

BenzingaOct 15 00:55

Raymond James Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $260

Futu NewsOct 14 22:31

BTIG Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $260

Futu NewsOct 14 20:31

Baird Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $280

Futu NewsOct 10 02:31

Insulet Analyst Ratings

BenzingaOct 2 00:22

Citi Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $275

Futu NewsOct 1 18:35

Insulet Is Maintained at Buy by Canaccord Genuity

Dow JonesSep 25 22:46

CCORF Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $269

Futu NewsSep 25 19:32

Insulet Analyst Ratings

BenzingaSep 17 19:52

Piper Sandler Maintains Insulet(PODD.US) With Buy Rating, Raises Target Price to $285

Futu NewsSep 17 19:31

Piper Sandler Sticks to Its Buy Rating for Insulet (PODD)

TipRanksSep 17 18:59

Morgan Stanley Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $234

Futu NewsSep 10 18:31

Wells Fargo Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $245

Futu NewsSep 5 17:33

Strong Growth and Market Leadership Support Buy Rating for Insulet

TipRanksSep 5 17:08

Jefferies Maintains Insulet(PODD.US) With Buy Rating, Maintains Target Price $260

Futu NewsAug 28 20:32

A Quick Look at Today's Ratings for Insulet(PODD.US), With a Forecast Between $230 to $264

Futu NewsAug 27 21:01

Piper Sandler Sticks to Their Buy Rating for Insulet (PODD)

TipRanksAug 27 18:42

Insulet's Omnipod 5 Expansion Into Type 2 Diabetes Market: A Strong Buy Rating

TipRanksAug 27 18:37

Buy Rating on Insulet: Early FDA Approval and Market Dominance Signal Strong Growth Potential

TipRanksAug 27 16:50